Analysis of Bevacizumab by SEC–MALLS

April 30, 2021
YMC Europe GmbH

Sponsored Content

In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.